A federal judge on February 16 dismissed a proposed class action lawsuit by consumers who accused Pfizer Inc. of failing to disclose the presence of cancer-causing agents in Chantix before recalling the anti-smoking drug.
HIV-prevention advocacy group PrEP4All Collaboration filed a petition with the U.S. Patent and Trademark Office alleging that Gilead Sciences intentionally delayed the development of a safer drug for human immunodeficiency virus.
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that it has reached an agreement with plaintiffs to resolve In re Merck & Co., […]
